9999999997-13-017791.txt : 20131231 9999999997-13-017791.hdr.sgml : 20131231 20131231140404 ACCESSION NUMBER: 9999999997-13-017791 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20131231 DATE AS OF CHANGE: 20131231 20131231 20131231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Synthetic Biologics, Inc. CENTRAL INDEX KEY: 0000894158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133808303 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-12584 FILM NUMBER: 131305413 BUSINESS ADDRESS: STREET 1: 155 GIBBS STREET STREET 2: SUITE 412 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: (734) 332-7800 MAIL ADDRESS: STREET 1: 155 GIBBS STREET STREET 2: SUITE 412 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ADEONA PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20081027 FORMER COMPANY: FORMER CONFORMED NAME: PIPEX PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20061214 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC DATE OF NAME CHANGE: 19970730 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0T(#`@;V)J#3P\+TQI;F5AF4@-3')E9@T*,`T*)25%3T8-"B`@("`@ M("`-"C4V(#`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`#=_A9@`/5I?&L- M"F5N9'-T]D-$%FDAN3,F3,7 MGIO?2C9^A0GV.EZ>G)6E9(J53R=*LU#" M-/P6DF4R%T7*RL4)9T'YQ\G%-:[U^RF[G\I9J(1*6#DY(*JMJ+22@P.2D9,4 M4D:L'(-&YNTC"R-1%/ZH>WX7)'P(_U>!YN7%`-[8;1`J7O;@M;RX#7XK?X`C M81.)ZS-1Y/AV2,O8GDU':EIG7N!L%8LLK1\.)Z7\(@@3WK^[N0K"B): M)@'6&PX8#7\-E.3][X,PYKWA=T&UEO5_QIGK(,SAHR$ZW4H:6U MD/$Q"F0=X":B2.K*DL$W`P+HAB%6-SW05/*AAY@@9#1K(!Q>!H7Y9!;69'L_ M$=0T<0,?5<)[-$#$K?`NO#H6LN@R/^\B"ZS>0?]N:(VA8XD$QOW_D$6&06WV M]/HDS@@!!("I(-2\P$>$C[AM5Z*Z["J<79$4.CGF5N6RBM(B+QH!$O//2WQN M@HA/\06IAH,9ZH9<9.=H*0U7X+;M"%)88 M1&/1M%BHJ,M@Y?)8F`@8'#/8Y;(P%4E<-_@R4,J80I:@K6P(#%L)1CIQ*7%' MKO"9^/`*<2Q%9-54.LECDB0-S/>H$8X$B[*P*+3TGO>#L."7W[00<%2.C`:) M3/S^+0M=#@X+H6LNY;_[/UK>&.[?S655J#/*U)D0N)(9:D4=2+MD5GY;B;A0 M"UVL198(F/DU_QQH#430?#.EC)?RS6R,F>(<@F.V@KGY"FGR'(`P??$L4U$% MIXY,N2/ MV0.\S=GF!;[@)`XW"_?9I')U M`-4^@G\T!,CT+B%:&-X;G.9.W<;^801A7\_!X'\7_+LY$4L\^GS\N,"*457V M%_0IU(3=;5-A2X!)!U75QU=A6&*I>R`RTUJ&B-*C*3-K!;)CX7F0$<6)?"86 MT$;D`C(<9]:.ITYH21'1#`W\#-:.:#4D@@[R4KK0_SU=>"P5(%"E"<@2+@V& MKG]U[:OTE1?RR'XO2I%;#HW)%?X@*=+B*)W(#`H2P_49F)UO#G5N8\R+#M+5:.I$)^<.[;69]1]L9:AZG&Y(KD_-, MGJ@V7U+FW",\HT1&6M"ZQ3[&["13^C"EI$EG7`)&%?4@H(B;1D^V>G+)%QA] M#]T:%(>E4ZSCO%Y@LCI-GD*[?@<3@CHET:<:(UB2Z/<<=AB]#^!)KS&]GK94 MQ*Z>MOZ3G@2_/CLER1I%%ZQ=;;T6YEFU<%.X(XG7C]Q]:%*Q//I(@OFH(Y$(DYJ(19;72G MHC6WP2T!--S@D[.+MMY.*F5QUBS>YS@T1486VF9>]8!@ MWNICL*>'Y-P>##I9]$>DELVE MKB]X0$[7DF[EI)HE+7\Q!U%=K-8PN/AE:TL/`]C$=""DO%8B;O6QS5+VBM5V M31>&\0PU?:J8#7$XP>DWC8P5"Q5W5BQ_7=,YUN5C)XA[N9 M:CHS-^RM.C8EA;\)Q*+8T5T)F1X_P[B`2+@E9DW9H>L2M0;J0&]0()RG#3AS M$:>[#(,&@0S*C0%[0=/2@US@#E\4.(;4^U!!]C4'K]*A#U:X;EN^%H3?WK336+=-?+ZC=P/^JM6BR M2KD;RNE.FV:2B$DH7Z&FH1IX/:G*^"GD-EQG;F4/KC&Q2=`VC8IZ(:50[5JJ MGM02*>Q(9'(J^.OFXV#DN$T5VE&5) MBV4MD?2XR,'F_7\/3+C[(O,7PHG0C5R;,677Z"1A?LAKZVE%',0Q%VEGWM>U MO)^B[+]-2<<&>]*ML^Z6\LN8\NSCQAAG+C80>)X(571$(LOK.VNA=:=IA3>M M95=3.)+['7U1GOPMP`"4Z5-Q#0IE;F1S=')E86T-96YD;V)J#30Y(#`@;V)J M#3P\+T9I;'1E+V!-+B@J`=('@-@H);4X&4A_`>+,\I(" MH#AC`I`MDI0-9H/4B62'!#D#V1U`-E]):@5(C,$YOZ"R*#,]HT3!T-+24L$Q M)3\I52&XLK@D-;=8P3,O.;^H(+\HL20U!:@6:@<(\+L7)58JN"?FYB8J&.D9 MD>AR(@`H+"&LSR'@,&(4.X\00X#DTJ(R*).1R9B!`2#``$G&."\-"F5N9'-T M7!E+T]B:E-T;3X^R4>65%!%22B1,%--$CSY@J)4Y#U5,9)GJA("/1X1*`5$I%0A M2JH+1$6U(!+5):*FNH[$!4",G('@`.^+5!(+R/B#`S(D0@N&-7&)I;`T8V7& M+C@A*R:NL78A).")!!+P!,L(>%*7).`%_(22#Q'GF#>9 M3$P"7HG3!/#*$&@^<(FS7%RX&[@H:.LVS9B[:3_F#"]_3ZSS\W237\B[;?^0 MOS0#G,T=^YMW. M[?)!C[L^/3[=SA>_="Q3EUW73\W4]IW;#4WGKNZ;<7+7[?$T9O>Q;8YC\_@V M'/OAJAE>AY^Z._R;W7K^7$/I[]'G[J'M\NZ^@?9S]]?3-,_I*KB*]F?N3]-Y M>/KQ=!C;X6TXY/'/B3VN]4/_["ZQM6_=71[?2*O5_WN#RY,O<(_G9W^D\'JC M&WV]>.=6EW?7E;F+>->5N9MYUY M6YJWK;%MC=]Y8[8UMJVQ;8UM:VQ;8]L:V];8MB;_M/9+@`$`5:R]L@T*96YD MFMC.60B/SX*/'@Z>&UP;65T M82!X;6QN#IX;7!T:STB061O8F4@6$U0 M($-O&UP.DUE=&%D871A1&%T93X*("`@("`@("`@/'AM<#I#&UP34TZ M&UP34TZ&UL.FQA;F<](G@M9&5F M875L="(O/@H@("`@("`@("`@("`\+W)D9CI!;'0^"B`@("`@("`@(#PO9&,Z M=&ET;&4^"B`@("`@("`@(#QD8SID97-C&UL.FQA;F<](G@M M9&5F875L="(O/@H@("`@("`@("`@("`\+W)D9CI!;'0^"B`@("`@("`@(#PO M9&,Z9&5S8W)I<'1I;VX^"B`@("`@("`@(#QD8SIC7=O#I3;W5R8V5-;V1I9FEE9#X*("`@("`@("`@/'!D M9G@Z0V]M<&%N>3Y396-U&AA;F=E($-O;6UI3X*("`@("`@("`@/'!D9G@Z0V]M;65N=',^5F5R[,BXL';R_"\S\M<&I"P M6+2KDH_$HJ2F7=/YC#$G\8R<`D50<_E]?;=Q%#MTA4,.F,!&#W>?1QM?$*92 M2!->44:;:^IM1M'?:JF,TD8IT]UH?2&[F92S'ZI.KAS38#-L^_N-/2&#DG,% M!V+8$_NF?<#QHX8DFG9#_C^G^75NF7QQ6*6>!IR4\!@&MCQ.UOK%C@H[K)YP M".C_BJZ[*]U5H`ROZ'(=>PKY#46S7'X),``C1EBJ#0IE;F1S=')E86T-96YD M;V)J#34@,"!O8FH-/#PO1&5C;V1E4&%R;7,\/"]#;VQU;6YS(#0O4')E9&EC M=&]R(#$R/CXO1FEL=&5R+T9L871E1&5C;V1E+TE$6SPT1D%!03!%.4$X,3@S M130T.3!",#(Y,CE!0S4S.#%%-CX\.#8U,C!&1D4U,40X.3(T1CE%0S4X.#8Q M-S%&0D%!,D8^72]);F9O(#0S(#`@4B],96YG=&@@-3`O4F]O="`T-2`P(%(O M4VEZ92`T-"]4>7!E+UA2968O5ULQ(#(@,5T^/G-T